NCT07903038
Lemborexant on Perioperative Sleep Quality in Patients With Parkinson's Disease Undergoing Deep Brain Stimulation
StatusNot Yet Recruiting
PhasePhase 2
SponsorBeijing Tiantan Hospital
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Total Sleep Time (TST) on the Night Before Surgery
Timeframe: Night before surgery
Secondary (11)
Perioperative subjective sleep quality
Postoperative objective sleep quality
Time to Extubation
Time to Awakening
Perioperative Anxiety Visual Analog Scale (VAS-A) Score
Show 6 moreShow less
Postoperative Hospital Anxiety and Depression Scale (HADS) Score
Postoperative pain measured by Pain Numeric Rating Scale (NRS) score
Postoperative Quality of Recovery-15 (QoR-15)
Postoperative delirium
Pittsburgh Sleep Quality Index (PSQI) Score at 1 Month After Surgery
Parkinson's Disease Questionnaire-39 (PDQ-39) Score at 1 Month After Surgery
Arms and interventions
Lemborexant 5 mgExperimental
Participants will receive a single oral dose of lemborexant 5 mg tablet on the night before surgery.
PlaceboPlacebo comparator
Participants will receive a single oral dose of matching placebo tablet on the night before surgery.
Drugs: Lemborexant 5 mg, Placabo